Mass photometry for AAV manufacturing: Faster downstream processing

With the rising demand for gene therapies using adeno-associated virus (AAV) vectors, maintaining high production quality is more critical than ever. Watch this webinar to learn:  

• How mass photometry accelerates early process development  

• Insights from a case study by ABL, a leading CDMO in viral vector manufacturing  

• How mass photometry enhances GMP-regulated environments and process optimization